Board Memberships
Eli Lilly & Co
Pharmaceuticals/Health Products
Smiley joined Lilly (LLY) in 1995 and was promoted to CFO in 2018. He resigned after an investigation revealed "inappropriate personal communications" with employees. The pharmaceutical company said an independent investigation was recently launched after it was "made aware of allegations of an inappropriate personal relationship" between Smiley and an employee. Under a separation agreement, Smiley will forfeit his $1 million 2020 bonus and about $3 million of his 2018-2020 shareholder value award, Lilly said in an SEC filing. He's additionally set to forfeit "all other current and future equity incentive awards" that are potentially worth more than $20 million, the company said.